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A prominent aqueous cavity is formed by the junction of three
identical subunits in the excitatory amino acid transporter (EAAT)
family. To investigate the effect of this structure on the interaction
of ligands with the transporter, we recorded currents in voltageclamped Xenopus oocytes expressing EAATs and used concentration jumps to measure binding and unbinding rates of a highafﬁnity aspartate analog that competitively blocks transport
(β-2-ﬂuorenyl-aspartylamide; 2-FAA). The binding rates of the
blocker were approximately one order of magnitude slower than
L-Glu and were not signiﬁcantly different for EAAT1, EAAT2, or
EAAT3, but 2-FAA exhibited higher afﬁnity for the neuronal transporter EAAT3 as a result of a slower dissociation rate. Unexpectedly, the rate of recovery from block was increased by L-Glu in a
saturable and concentration-dependent manner, ruling out a ﬁrstorder mechanism and suggesting that following unbinding, there
is a signiﬁcant probability of ligand rebinding to the same or
neighboring subunits within a trimer. Consistent with such a mechanism, coexpression of wild-type subunits with mutant (R447C)
subunits that do not bind glutamate or 2-FAA also increased the
unblocking rate. The data suggest that electrostatic and steric factors result in an effective dissociation rate that is approximately
sevenfold slower than the microscopic subunit unbinding rate. The
quaternary structure, which has been conserved through evolution, is expected to increase the transporters’ capture efﬁciency
by increasing the probability that following unbinding, a ligand
will rebind as opposed to being lost to diffusion.
synaptic transmission
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embers of the SLC1 solute carrier family include transporters for acidic (EAAT1–5; SLC1A1–3, 6, 7) and neutral
(ASCT1, 2; SLC1A4, 5) amino acids in mammals. Recent phylogenetic studies indicate the existence of at least two additional
members of this gene family (SLC1A8, 9) that were lost in the
lineage leading to mammals (1). The mammalian excitatory
amino acid transporters (EAAT1–5) are secondary active transporters that help terminate glutamatergic synaptic transmission
within the central nervous system by removing transmitter (L-Glu)
from the extracellular space (2). EAATs can maintain an intracellular-to-extracellular L-Glu concentration ratio exceeding
106 by stoichiometrically coupling L-Glu transport to cotransport
of 3 Na+, 1 H+, and 1 L-Glu and countertransport of 1 K+ (3, 4).
The crystal structure of the outward-facing state of the archaeal glutamate transporter homolog GltPh features a prominent
aqueous cavity framed by three subunits forming a homotrimer
(5, 6). One aspartate/glutamate binding site in each subunit faces
the aqueous cavity near its base, approximately halfway across
the plane of the lipid bilayer. Functional and biochemical studies
of homologous mammalian glutamate transporters are consistent
with this trimeric structure and indicate that each subunit functions as an independent transporter (7–9). The recent structural
determination of the inward-facing form of GltPh suggests a
unique mechanism for alternating access ﬂux coupling that involves a relative motion of the central subunit core, including the
substrate binding site, across the bilayer while the intersubunit
contacts remain relatively ﬁxed (10). Although the alternating
access cycle is signiﬁcantly slower than the time course of the
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synaptic transmitter transient, glutamate transporters can also
function on faster timescales by buffering transmitter diffusion
(2). In this study, we investigated the potential role of the central
aqueous cavity in inﬂuencing the diffusion of transporter ligands.
The nontransported aspartate analog β-2-ﬂuorenyl-aspartylamide
[(S)-4-(9H-ﬂuoren-2-ylamino)-2-amino-4-oxobutanoic acid; 2-FAA]
has been reported to block glutamate uptake with nanomolar afﬁnities and 10-fold selectivity for the neuronal transporter EAAT3
over EAAT1 and EAAT2 (11). The effects of 2-FAA concentration
jumps on glutamate transporter currents revealed that the macroscopic recovery from block was approximately sevenfold slower
than the microscopic unbinding rate from an individual subunit. We
hypothesize that the central cavity and symmetrically juxtaposed
binding sites enhance the transporters’ capture efﬁciency by slowing
the loss of unbound ligand to the bulk medium.
Results
2-FAA Effects on Steady-State Transport Currents. In oocytes
expressing EAAT3, application of 30 μM L-glutamate induced
inward currents that reached steady state within a few seconds,
whereas coapplication of L-glutamate with 30 nM 2-FAA induced
a fast inward current followed by a slow relaxation to a reduced
steady-state level (Fig. 1A). When the oocyte was preequilibrated
for 5 min with 30 nM 2-FAA, the slow relaxation phase was
absent but an identical fractional block of the steady-state Lglutamate current was observed (Fig. 1B). These data are similar
to results seen with the high-afﬁnity EAAT blocker (2S,3S)3-[3-[4-(triﬂuoromethyl)benzoylamino]benzyloxy]aspartate (TFBTBOA) (12), and suggest that a slow 2-FAA block develops
concomitantly with activation of the transport current. To more
directly observe the pre-steady-state kinetics of the onset and
offset of 2-FAA block, it was applied after the current induced by
3 μM L-glutamate reached steady state, and then 2-FAA was
washed out in the continued presence of L-Glu (Fig. 1 C and D).
The rate at which 2-FAA blocked the steady-state Glu current
was notably slower at 10 nM than 300 nM (Fig. 1 C and D).
2-FAA Blocking Kinetics. The 2-FAA concentration dependence of
the EAAT3 blocking rate was systematically examined by rapidly
applying varying concentrations of drug to oocytes preequilibrated with 3 μM L-glutamate and measuring the relaxation of the
steady-state transport currents induced by application and washout of the drug (Figs. 1D and 2A). The time constant for solution
exchange in the recording chamber was 2–3 s (10–90% rise time
4.0 ± 0.3 s; Fig. 1D Inset), corresponding to a rate $10-fold faster
than the rate of onset and offset of 2-FAA block at the highest
concentration measured (100 nM). Representative experiments
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where T is the transporter, B is the blocking drug, and D is the
blocked transporter, with forward and backward rate constants
f and b. The integrated pseudo-ﬁrst-order rate equation for this
mechanism predicts a linear relationship between the blocking
rate and the blocker concentration, where the slope is equal to
the binding rate f, and the y intercept is equal to the unbinding
rate b:
blocking rate ¼ f ½2 − FAA þ b:

[2]

Linear regression of the mean [2-FAA] blocking rate data for
EAAT3 represented in Fig. 3B gives a slope of 4.4 × 105 M−1s−1
and a y intercept of 3.8 × 10−3 s−1, resulting in a Ki estimate of
8.6 nM (b/f).

measuring the onset of 2-FAA block illustrate that the time dependence of the steady-state current decay was well-ﬁtted by
a single exponential process (Fig. 2A). The reciprocals of the
mean time constants were proportional to [2-FAA] over the range
3–100 nM (Fig. 2B). At higher concentrations of 2-FAA (300–
3,000 nM), the blocking rate plateaued near 0.3 s−1, which reﬂects
the limit of the solution-exchange time constant of the chamber.
At an L-Glu concentration of 3 μM, only a small fraction (w6%)
of the transporter subunits are occupied, assuming an EAAT3 Km
of 44 μM (9). If the effect of substrate is neglected, a kinetic
analysis of block follows from the simple reaction mechanism
f

T þ B % D;
b

[1]

Fig. 2. The blocking kinetics of 2-FAA on EAAT3 transporter currents. (A)
Representative traces from a single oocyte showing the decay of the steadystate transport current (3 μM L-Glu) following a jump into 3, 10, 30, or
100 nM 2-FAA (Vm = −60 mV). Data are ﬁt to a single exponential (gray). (B)
Linear regression of the blocking rates of the L-Glu (3 μM) transport current
as a function of 2-FAA concentration. Fit shows slope of 4.39 ± 0.75 × 105
M−1s−1 (circles) and a y intercept of 0.0038 ± 0.0007 s−1. The recovery from
block for EAAT3 was independent of the concentration of 2-FAA at 10, 30,
and 100 nM (squares). Each point represents mean and SEM of between
3 and 16 experiments.

Leary et al.

where I(t) is the current amplitude at time t, I(ss) is the ﬁnal
steady-state current amplitude, and τ is the time constant. The
mean value of 1/τ was 4.0 ± 0.2 × 10−3 s−1, not signiﬁcantly
different from the value of 3.8 × 10−3 s−1 determined from the
extrapolated blocking rate data using the pseudo-ﬁrst-order approximation (Fig. 2B). 2-FAA has been reported to exhibit selectivity for the neuronal glutamate transporter EAAT3 over the
glial transporters EAAT1 and EAAT2 (11, 13). The 2-FAA concentration dependence of block of 3 μM L-Glu transporter current reﬂected these differences for EAAT1, 2, and 3, with IC50
values of 53.7 ± 6.1 nM, 59.0 ± 6.3 nM, and 5.7 ± 0.5 nM,
respectively (Fig. 3A). It was not possible to accurately estimate
the 2-FAA binding rates for the lower-afﬁnity EAAT1 and
EAAT2 transporters because the solution-exchange kinetics limited measurements at higher drug concentrations. However, the
rates of recovery from block for EAAT1 and EAAT2 were measured and found to be seven- to eightfold faster than EAAT3
(3.1 ± 0.2 × 10−2 s−1, 2.8 ± 0.3 × 10−2 s−1, and 4.0 ± 0.2 × 10−3 s−1,
respectively; Fig. 3B). After determination of Ki values from the
IC50 for the respective transporters using Ki = IC50/(1 + [L-Glu]/
Km) (Methods), binding rates for EAAT1 and EAAT2 were

Fig. 3. A slower unbinding of 2-FAA from EAAT3 accounts for the increase
in afﬁnity over EAAT1 or EAAT2. (A) The steady-state percent block of 2-FAA
for the 3 μM L-Glu transporter current: EAAT1 (diamonds; IC50 = 53.7 ± 6.1
nM), EAAT2 (squares; IC50 = 59.0 ± 6.3 nM), and EAAT3 (circles; IC50 = 5.7 ±
0.5 nM; Vm = −60 mV). Each point represents between 3 and 30 measurements. (B) Representative traces showing the recovery of the steady-state
transport current (normalized) from block of 2-FAA. Reciprocal of the single
exponential ﬁts gave rates of 0.031 ± 0.002 s−1, 0.028 ± 0.003 s−1, and 0.0040 ±
0.0002 s−1 for EAAT1, 2, and 3, respectively (n = 5).
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Fig. 1. Effects of 2-FAA on EAAT3-mediated glutamate transport currents.
(A and B) Application of 30 μM L-Glu alone or coapplied with 30 μM 2-FAA
showing transient inward current that decays to steady state (A), whereas
prior application of 2-FAA for 5 min (B) results in the same fractional steadystate block without a transient current. (C) Representative recording illustrating block and recovery from block of the steady-state L-Glu current
(3 μM) by 2-FAA (300 nM). (D) Onset and recovery from block of steady-state
L-Glu current by an 800-s application of 10 nM 2-FAA (note concentration
differences). Solution-exchange kinetics show response (inverted) to an 800-s
pulse of L-Glu (3 μM; Vm = −60 mV).

2-FAA Unbinding and EAAT Subtype Selectivity. In contrast to the
blocking rate, the recovery from block following 2-FAA washout
was independent of [2-FAA], as expected for a ﬁrst-order unbinding reaction. The unblocking rate of 2-FAA was estimated
from the least-squares ﬁt of the recovery of the blocked current
to its initial steady-state value following drug washout to the
following equation:


IðtÞ ¼ IðssÞ 1 − eð − t=τÞ ;
[3]

estimated to be 6 ± 1 × 105 M−1s−1 and 5 ± 1 × 105 M−1s−1,
respectively. These values were similar to the slope measured
from the EAAT3 blocking rate (4.4 × 105 M−1s−1; Fig. 2B).
Together, these data indicate that the selectivity for EAAT3 is
a result of a slower unbinding rate of the drug from EAAT3. The
afﬁnity determination of 2-FAA for EAAT3 based on current
block was also in good agreement with its block of D-[H3]aspartate uptake (Fig. S1).
Anomalous Unblocking Kinetics. Unexpectedly, the rate of recovery
of the transport current from 2-FAA block exhibited a clear
dependence on the L-Glu concentration (Fig. 4A). The ability of
L-Glu to accelerate the unbinding of 2-FAA is inconsistent with
a ﬁrst-order kinetic mechanism. There is no evidence for an allosteric glutamate binding site based on structural data (6), and
the concentration dependence of steady-state transport also
suggests that a single glutamate binding site exists on each subunit that displays no measurable cooperativity with other subunits (9). Computational docking of 2-FAA predicts overlap with
the glutamate binding site (see below), and 2-FAA displays
competitive inhibition of glutamate transport, as higher concentrations of L-Glu can overcome 2-FAA inhibition (Fig. S1).
These data argue against an allosteric linkage that would account
for the effect of L-Glu on the 2-FAA unbinding rate. An alternative mechanism is suggested by the fact that the three aspartate/glutamate binding sites line the aqueous cavity formed by
the three subunits, which could form an effective diffusion barrier
retarding the escape of ligand to the bulk medium. Following ligand unbinding, if the probability of rebinding to the same or
other subunits in a trimer were signiﬁcant relative to the probability of loss to the bulk medium, the presence of L-Glu would
increase the apparent unbinding rate of 2-FAA because of competition for rebinding. This model predicts that in the presence of
saturating L-Glu, the unblocking rate would approach the true
ﬁrst-order individual subunit unbinding rate because rebinding
would be effectively blocked. Consistent with this prediction, the
unblocking rate increased with [L-Glu] in a saturable manner, with
an EC50 value of 7.4 ± 2.4 μM (Fig. 4B). In addition to increasing
the recovery rate as glutamate concentration increased, the time
course of unblock became better-ﬁtted with a single exponential
decay time constant (χ2 value was reduced from 17.4 at 3 μM to
0.7 at 100 μM L-glutamate; P < 0.001; Fig. 4A). Overall, these data
are consistent with a signiﬁcant probability of ligand rebinding,
with reduction to a ﬁrst-order kinetic scheme when 2-FAA rebinding is prevented by saturating L-Glu.
Unblocking Kinetics in the Absence of Glutamate. To further examine the mechanisms underlying the complex 2-FAA unblocking
kinetics, recovery from block was measured in the absence of

Fig. 4. Recovery kinetics depend on [L-Glu]. (A) Recovery from 100 nM 2-FAA
block of the normalized steady-state transport current induced by 3, 30, or 100
μM L-Glu. The experiment was performed as in Fig. 1C. Fractional block is
normalized to the amplitude of the steady-state current in the presence of 2FAA and the indicated concentration of L-Glu. The traces were ﬁt to single
exponential decay (dashed), and the goodness of ﬁt was quantiﬁed by χ2
measurement (3 μM χ2 = 17.4, 30 μM χ2 = 2.2, 100 μM χ2 = 0.7; Vm = −60 mV). (B)
Summary of the effect of [L-Glu] on recovery from block (rates determined by
single exponential ﬁts) showing a saturable concentration dependence.
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by taking advantage of the fact that nontransported
blockers immobilize an Na+-dependent nonlinear capacitive
charge movement in the absence of substrate (Fig. 5A) (14, 15).
Consistent with earlier studies, the charge blocked by 2-FAA was
conserved during equal and opposite voltage steps, and the charge
recovery from block could be monitored by integration of the
transient currents recorded at intervals following washout of
2-FAA (Fig. 5A Inset). In the same manner, the rate of onset of
block was measured, which had a 2-FAA concentration dependence that was not signiﬁcantly different from the blocking
rate of the steady-state glutamate transport current (3.9 ± 0.6 ×
105 M−1s−1; Figs. 2 and 5 B and C). However, the unblocking rate
was signiﬁcantly slower than the unblocking rates measured in the
presence of glutamate (P < 0.01). The difference in the kinetics of
recovery from block in the presence and absence of 100 μM
L-glutamate is graphically shown in Fig. 5D. The ratio of the recovery rates in the presence and absence of L-Glu indicates that
100 μM L-Glu accelerated the effective unbinding rate 6.9-fold
(7.6 × 10−3 s−1/1.1 × 10−3 s−1). To investigate the L-Glu concentration dependence of the recovery from block, pulses of varying
[L-Glu] were applied during the 2-FAA washout phase and the
recovery of the charge movement was determined after L-Glu
washout. The effect of L-Glu on the recovery rate of charge
movements was saturable and concentration-dependent, with an
EC50 of 10.5 ± 2.6 μM (Fig. 5D Inset).
Kinetic Effects of Introducing R447C Mutant Subunits into a Trimer.

To test the possibility that the deviation from ﬁrst-order unbinding kinetics involved ligand rebinding to neighboring subunits, wild-type EAAT3 subunits were coexpressed with EAAT3
R447C subunits. The R447C mutation targets a residue in the
substrate binding site and changes the electrostatics of EAAT3
substrate recognition, converting acidic amino acid selectivity to
neutral amino acid selectivity (7, 9, 16). Wild-type EAAT3 does
not mediate measurable uptake or display currents in response
to 100 μM L-alanine superfusion. In contrast, application of
L-alanine induced saturable currents mediated by transporters
composed of homotrimers of EAAT3 R447C mutant subunits,
and these currents were insensitive to coapplication of 1 μM 2FAA (Fig. 6A Inset). R447C transporters also mediated uptake
of L-[H3]alanine that was similarly insensitive to 2-FAA (Fig.
6A). Furthermore, in the absence of alanine, 500 nM 2-FAA did
not block any detectable capacitive charge movement in cells
expressing R447C subunits. To examine the effect of changing
the number of subunits capable of binding 2-FAA in a trimer, we
coinjected oocytes with cRNA composed of 25% wild-type with
75% R447C mutant cRNAs. Assuming a random binomial distribution of subunits in trimers, the expected proportions of
trimers containing 3, 2, 1, or 0 wild-type subunits is 0.253 (1.5%),
3$0.252$0.75 (14.1%), 3$0.25$0.752 (42.2%), and 0.753 (42.2%),
respectively. Thus, of the trimers capable of binding 2-FAA, the
majority (73%) have only one wild-type subunit, 24% have two
wild-type subunits, and 3% have three wild-type subunits. As
would be predicted if ligand rebinding to adjacent subunits occurred with a signiﬁcant probability, coexpression of R447C with
wild-type subunits increased the recovery rate of the transient
charge movements in the wild-type subunits following washout
of 100 nM 2-FAA (2.7 × 10−3 s−1 vs. 1.1 × 10−3 s−1, respectively,
P < 0.01; Fig. 6B).

Computational Models of 2-FAA Interactions with EAAT3. To model
the structural and functional interaction of 2-FAA with EAAT3,
we performed computational docking and developed a minimal
kinetic scheme consistent with the data that explicitly incorporates diffusional effects of the aqueous cavity. 2-FAA and TBOA
were computationally docked into a model of EAAT3 based on
the GltPh-TBOA structure (17). The crystal structures of GltPh
bound with L-aspartate or L-8-Br-TBOA (6) suggest that although both ligands electrostatically interact with an arginine
residue in the position equivalent to R447 in EAAT3, L-aspartate
is occluded by closure of the HP2 loop structure whereas the
arylaspartate blocker prevents loop closure (Movie S1). The
computational docking algorithm (Methods) predicted similar
Leary et al.

electrostatic interactions for aspartate, TBOA, and 2-FAA with
EAAT3 R447 and D440, but hydrophobic interactions determining the planar ring orientation of 2-FAA differed signiﬁcantly from those of TBOA (6). For 2-FAA, which displays
approximately two orders of magnitude higher afﬁnity for
EAAT3 than TBOA, the most energetically favorable docked
structures positioned the aromatic rings in a nonpolar groove
lined by residues from TM7, TM8, and the HP2 loop, whereas
the benzene ring of the crystal structure of TBOA is oriented
toward the solvent-accessible tip of the HP2 loop (Fig. 7A). The
ChemScore values from the GOLD docking algorithm for
2-FAA docking in the two positions were 22.4 and 18.9, respectively. A representation of a bound 2-FAA molecule showing
the relative scale of the central cavity is shown in Fig. 7B.
A system of ordinary differential equations was derived for
a minimal kinetic model that incorporates an extra state representing unbound 2-FAA occupying the central aqueous cavity.
In this model (Fig. 7C), the cavity forms a signiﬁcant diffusion

barrier and a molecule within it can either bind to a transporter
subunit at rate f2, or it can exit the cavity to the bulk medium with
a rate b2 (Fig. 7C). The value of the intrinsic subunit unbinding
rate, b1, was ﬁxed to the unblocking rate measured in saturating
concentrations of L-Glu (0.0076 s−1; Fig. 3C). Using the Simplex
algorithm (MATLAB Optimization Toolbox; The MathWorks),
this model was capable of ﬁtting the data well (Fig. 7D). However, the parameters b2 and f2, the rates for the two routes of
ligand exit from the central cavity, could not be reliably deﬁned
as independent variables and were instead ﬁtted as a ratio after
model reduction using the boundary function method (18)
(Fig. S2). The block and unblock data were well-ﬁtted by the
model with a ratio f2/b2 = 2.91 [Fig. 7D; 95% conﬁdence interval
(CI) 2.80–3.02], suggesting a molecule once in the cavity is more
likely to bind to a subunit than be lost to the bulk medium. The
model also produced good ﬁts for the unblocking data in both
the absence and presence of saturating L-Glu, in contrast to the
kinetic model previously assumed to apply (Fig. 7E).
Discussion
Structural and Functional Features of the Aqueous Cavity and Ligand
Binding Sites. A notable structural feature of the trimeric gluta-

Fig. 6. Incorporation of selectivity mutant R447C subunits into trimers
increases the apparent off rate of 2-FAA. (A) Radiolabeled L-[3H]Ala (3 μM)
uptake by hEAAT3 R447C is not blocked by 2-FAA (500 nM). (Inset) The hEAAT3
R447C L-Ala current is similarly not blocked by 2-FAA (1 μM). (B) The recovery
from 2-FAA (100 nM) block of the Na+-dependent charge movements in oocytes
expressing heterotrimers of hEAAT3 and hEAAT3 R447C at a ratio of 1:3 (closed
circles; n = 15) compared with oocytes expressing homotrimers of hEAAT3 (data
from Fig. 5D; n = 10). Data are ﬁt to single exponential decay functions.

Leary et al.

mate transporter family is the central cavity formed by the junction of the three wedged-shaped subunits. Because the surface
of this water-ﬁlled cavity is predominately hydrophilic and it
dips approximately halfway into the plane of the membrane, it is
possible that it serves to lower the energy barrier for glutamate
and cotransported ions to cross the lipid bilayer (5, 19). An additional possible role in modifying ligand diffusion is suggested
by the kinetics of 2-FAA interactions with EAAT3 described
here. Computational docking results with EAAT3 suggest that 2FAA interacts speciﬁcally with the aspartate/glutamate binding
site, although some signiﬁcant differences with the crystal structure of GltPh complexed with the arylaspartate blocker TBOA
were predicted (6). An alteration of the orientation of the tricyclic
aromatic group was required to accommodate the 2-FAA molecule in the ligand binding site. This predicted docking orientation
preserved the same electrostatic interactions observed in the
TBOA complex, but the tricyclic ﬂuorenyl group of 2-FAA ﬁt into
PNAS | September 6, 2011 | vol. 108 | no. 36 | 14983
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Fig. 5. The kinetics of 2-FAA (10 nM) block of transient
currents. (A) Capacitive transient currents induced by steps
from −80 to +20 mV. Representative traces show blocked
currents (Icontrol − I2-FAA) recorded at 3, 15, and 20 min after
washout. (Inset Top) Correlation of the 2-FAA-sensitive transient currents for on- and off-voltage steps demonstrating
conservation of charge movements. (B) Representative data
showing [2-FAA] dependence of rate of charge-movement
block for a single oocyte. (C) Linear regression of block and
unblock rates; slope = 3.85 ± 0.59 × 105 M−1s−1; y intercept of
0.0012 ± 0.0004 s−1 (n = 3–7). (D) A comparison of the recovery from 100 nM 2-FAA block of the 100 μM L-Glu
steady-state current (circles) and the Na+-dependent charge
movements (squares). Both datasets are ﬁt to a single exponential decay (τ = 131 s and 917 s, respectively). (Inset)
The normalized [L-Glu] dependence of charge-movement
recovery measured at 600 s, following a 270-s pulse of L-Glu
at the indicated concentrations.

rate of unblock. These behaviors are inconsistent with immediate
diffusional loss to the bulk medium after ligand unbinds, suggesting the possibility that the aqueous cavity presents a signiﬁcant
diffusion barrier. This effect does not involve intertrimer interactions because the unblocking kinetics were independent of
transporter expression level. The simplest kinetic model that ﬁts
the data features a distinct state in which a ligand molecule
occupies the aqueous cavity with a lifetime governed by rates f2
and b2, the rates of binding to a subunit and release to the bulk
medium, respectively (Fig. 7C). As the ratio of f2 to b2 approaches
zero, the model collapses to a pseudo-ﬁrst-order kinetic scheme.
The data and model suggest that the steric and electrostatic features of the cavity and the opposing two binding sites together
effectively reduce b2, the diffusional loss of ligand following subunit unbinding. The sevenfold difference in the rate of recovery
from 2-FAA block in the absence and presence of saturating Lglutamate indicates a >80% probability of 2-FAA rebinding to
the same or other subunits in a trimer following unbinding in
the absence of glutamate. Coexpression of nonbinding R447C
subunits increased the rate of unblock approximately twofold,
signiﬁcantly less than the sevenfold effect of saturating L-Glu,
suggesting that whereas the electrostatics of the binding sites
lining the aqueous cavity contribute to retarding ligand loss, steric
effects of the cavity itself appear to play a dominant role.

Fig. 7. Computational modeling of 2-FAA interactions with EAAT3. (A) The
ﬂuorene group of docked 2-FAA (orange) interacts with polar (green) and
nonpolar (gray) residues in TM7, TM8, and in the HP2 loop; the R447 surface
charge is highlighted with blue. TBOA (yellow) orientation from the GltPh
crystal structure overlaid. (B) Surface rendering of EAAT3 model showing central cavity, blocker, and selectivity site. (C) Kinetic scheme incorporating a central aqueous cavity that acts as a diffusion barrier. The black dots in the model
represent a molecule of 2-FAA either bound to a subunit (Dn) or centrally localized to the aqueous cavity (Dn*) of the EAAT3 trimer. (D) Blocking rate and
recovery from block data of the Na+-charge movements for 3, 10, and 30 nM
concentrations of 2-FAA (open circles) ﬁt to the model (Fig. S2). (Inset) Recovery
from 10 nM 2-FAA block comparing the goodness of ﬁt for the ﬁrst-order reaction scheme from equation 1 (dashed line) with the diffusion barrier model
(solid line). (E) Recovery from 10 nM 2-FAA block showing model best ﬁts (95%
CI) to the data in the absence (b1 = 0.0078–0.0080 s−1; f2/b2 = 3.04–3.12) or
presence of 100 μM L-glutamate (b1 = 0.0078–0.0080 s−1; f2/b2 = 0.04–0.05).

a novel hydrophobic groove between TMD7 and the HP2 loop of
the transporter (Fig. 7A).
The unique disposition of the three ligand binding sites within
the central aqueous cavity suggested the possibility that the cavity
might affect the kinetics of solute interaction with the transporters, and we sought to explore this possibility using a perturbation approach (20–25). The slow on and off rates for 2-FAA
block of EAAT currents facilitated measurement of the reaction
kinetics using a voltage clamp with a standard fast-ﬂow intracellular recording chamber. The steady-state and pre-steady-state
data conﬁrm the high afﬁnity and relative selectivity of 2-FAA for
EAAT3 (11). Binding rates of 2-FAA at all three EAATs were
similar and, as predicted by pseudo-ﬁrst-order blocking kinetics,
the lower equilibrium binding constant of 2-FAA for EAAT3 was
proportional to the slower rate of unblock observed at EAAT3
compared with EAAT1 and 2. However, experiments designed to
measure ﬁrst-order unbinding kinetics by rapid washout of blocker
led to three unexpected observations that were fundamentally
inconsistent with the previously assumed kinetic mechanism. First,
the rate of recovery from 2-FAA unblock was increased approximately sevenfold by L-glutamate in a concentration-dependent
and saturable manner. Second, the recovery from block following
washout of 2-FAA was well-ﬁtted by a single exponential decay
with saturating concentrations of glutamate present, but at lower
glutamate concentrations the decay was clearly a multiexponential
process. Third, trimers formed by coassembly of wild-type and
mutant subunits that do not bind ligand exhibited an increased
14984 | www.pnas.org/cgi/doi/10.1073/pnas.1108785108

Implications for Substrate Transport. One measure of the efﬁciency
of membrane transport under physiological conditions is the
probability that following binding, a molecule of substrate will
be transported to the intracellular space before unbinding to the
extracellular space. Concentration jump studies with glutamate
transporters in outside-out patches suggest that following binding
of glutamate, there is a signiﬁcant ($w0.5) probability of unbinding rather than membrane translocation (2, 22). In general,
the probability of unbinding from the initial bound state reﬂects
a balance between the opposing microscopic kinetic requirements for a rapid cycling rate and a high capture efﬁciency, because a very low unbinding rate reﬂects an energetically favorable
and stable complex, which would tend to slow the turnover rate.
A diffusion barrier in the form of an aqueous cavity as proposed
here would not slow the microscopic subunit unbinding rate but
would result in a kinetic advantage by slowing the effective loss of
substrate to the bulk space. At saturating substrate concentrations
this advantage will be insigniﬁcant, because substrate lost to the
bulk would rapidly be replaced by diffusion. However, during the
rapid decay of synaptic transmitter transients, this could provide a
mechanism to modulate the buffering kinetics (26). In addition, at
low ambient substrate concentrations, the advantage of such a
diffusion barrier could be signiﬁcant. In mammalian brain, the ion
gradients coupled to glutamate ﬂux can theoretically support lownanomolar extracellular glutamate concentrations at equilibrium
(3, 4). Measurements of basal glutamate receptor activity in hippocampus indicate an ambient glutamate concentration of 25 nM
(27), which is within the limits of the transporters’ equilibrium
thermodynamics but approximately three orders of magnitude
below their Km values. Under these steady-state conditions, the
transporters are working at a small fraction of their maximal
turnover rates in the face of robust tonic glutamate release (28),
suggesting that an increase in capture efﬁciency could be an important factor in extending the dynamic range of the transporters
to prevent tonic receptor activation. It is also tempting to speculate
that the early evolutionary appearance of this quaternary feature in
transporters of archaeal organisms might have conferred an advantage by increasing efﬁciency in scavenging dilute amino acids in
an environment where substrate diffusion could be rate-limiting.

Methods
Electrophysiology and Radiolabel Uptake. Approximately 50 ng of human
EAAT1, EAAT2, or EAAT3 cRNA was microinjected into stage V–VI Xenopus
oocytes and recordings were made 3–5 d later. For coexpression of wild-type
and mutant R447C transporter subunits, plasmid DNA was optically quantiﬁed, combined, and then linearized and transcribed. The magnitude of
oocyte currents elicited by L-Glu or L-Ala application was consistent with binomial dilution ratios (16). Recording solution (frog Ringer) contained 96 mM
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transporter states and species. Model simulations and ﬁtting of model solution to experimental data with the aim of identifying model parameters
were performed using MATLAB software package (v. 7.9.0.529) and MATLAB
Optimization and Statistics Toolboxes on a Macintosh computer (The
MathWorks). Parameter estimates are given with 95% CI. The boundary
function method (18) was used for asymptotic model reductions. In particular, the central-cavity barrier model originally containing seven differential
equations and four parameters was reduced to a simpler model containing
four differential equations and three parameters using this method, with
the assumption that the magnitudes of the diffusional rates f2 and b2
exceeded other rates by >100-fold. The solution of the reduced model was
a good approximation of the original model solution with the parameter
values estimated from experimental data.

Computational Modeling. Human EAAT3 sequence (GenBank; http://www.
ncbi.nlm.nih.gov) was aligned with the Protein Data Bank (PDB) sequences for
GltPh (PDB ID code 2NWW) (5, 6). The EAAT3 homology model was constructed
by threading the aligned sequence along 2NWW coordinates using the SwissProt server (http://swissmodel.expasy.org/). The resulting model was optimized through local energy minimizations of regions with high steric and
electrostatic interference using the AMBER7 force ﬁeld in the Tripos SYBYL 8.0
platform. Representations of 2-FAA and TBOA were docked using GOLD v.
3.0.1 (http://www.ccdc.cam.ac.uk) into the EAAT3 model and evaluated using
the ChemScore scoring function. Each of the top 30 poses for each of three
separate docking runs were evaluated for their capacity to hydrogen bond
with EAAT3 R447 and D444 residues. Poses with the lowest estimated ΔG
values determined by ChemScore were incorporated into the homology model
and visualized using PyMOL v. 1.3 (www.pymol.org).

Synthesis of 2-FAA. N-tBoc-L-aspartate (0.936 g, 4.35 mmol) was dissolved in
acetic anhydride (20 mL, 20× wt). The solution was stirred for 6 h at 60 °C. The
acetic anhydride was removed in vacuo and consecutive washes with toluene
(2 × 10 mL) and hexanes (2 × 10 mL) followed, leaving N-tBoc-L-aspartic anhydride as previously described (29). The crude white solid was used without
further puriﬁcation for nucleophilic addition to the anhydride, similar to the
method previously reported (30). The N-tBoc-L-aspartic anhydride was dissolved in anhydrous DMSO (80 mL, w0.05 M) followed by addition of 2-aminoﬂuorene (0.684 g, 90%, 0.85 eq), and the solution was stirred at 60 °C
overnight. Upon completion as determined by TLC, the reaction solution was
diluted with brine (200 mL) and the pH was adjusted to w2 by addition of
concentrated H3PO4. The aqueous solution was then extracted with CH2Cl2
(400 mL) and washed with brine (6 × 250 mL aliquots) adjusted to pH w2 to
remove remaining DMSO. The organic layer was then dried over MgSO4, ﬁltered, and concentrated to a dark oil. This oil was separated by silica gel (95%
CH2Cl2/4% methanol/1% acetic acid), collecting N-tBoc-2-aminoﬂuorenyl-Laspartylamide at Rf = 0.15, which was subsequently concentrated to a white
solid. The isolated N-tBoc-2-ﬂuorenyl-L-aspartylamide (0.697g, 1.758 mmol)
was dissolved in 1:1 CH2Cl2:TFA (6 mL) and allowed to stir at room temperature
for 1 h. The solution was aspirated with compressed air until dry, washed three
times with 10 mL CH2Cl2, ﬁltered, and again dried. The solid residue was then
resuspended into 0.01 M HCl (1.2 eq) via sonication, frozen, and placed in
a lyophilizer until dry leaving an off-white solid, 2-ﬂuorenyl-aspartylamide
(2-FAA; 0.555 g, 1.67 mmol; Fig. S3).

Kinetic Modeling. Kinetic models for glutamate transporter block were formulated as systems of ordinary differential equations for fractions of various
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NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, and 5 mM Hepes (pH 7.4).
Microelectrodes were pulled to resistances between 1 and 3 MΩ ﬁlled with 3 M
KCl. Data were recorded with Molecular Devices ampliﬁers and analog–digital
converters interfaced to PC or Macintosh computers. Data were analyzed offline with Axograph X (v. 1.0.8, www.axograph.com) and KaleidaGraph (v. 3.6;
Synergy) software. A 3 × 3 × 20-mm recording chamber was fashioned from
perspex that allowed high laminar ﬂow rates with continuous perfusion at 16–
20 mL/min and rapid valve control to change solution. Solution exchange of the
bath was monitored by currents induced in response to solution change to
hypertonic Ringer (supplemented with 20 mM KCl) or to 3 μM L-glutamate in
normal Ringer. Time constants for the solution exchange were estimated by
ﬁtting current amplitude changes to the expression At = A0$e−t/τ following
solution exchange. Concentrations of drug used for blocking rate measurements were less than 300 nM, resulting in time constants that were at least 10fold greater than the time constant of the solution exchange. Ki values were
estimated from the IC50 for the respective transporters using a modiﬁed form
of the Cheng–Prusoff equation: Ki = IC50/(1 + [L-Glu]/Km), assuming a Km value
for L-Glu of 44 μM (9). Transporter-associated Na+-dependent charge movements were recorded as in ref. 14. Uptake of L-[3H]Ala or D-[3H]Asp into oocytes
expressing EAAT3 was measured following preequilibration in Ringer containing the indicated concentration of 2-FAA for 5 min before being transferred to wells containing radiolabeled substrates with the same concentration
of 2-FAA. Oocytes were incubated in radiolabel for 5 min and then washed
three times in cold Ringer and lysed, and radioactivity was measured (14).

